Next Article in Journal
Identification of Novel Anti-Liver Cancer Small Molecules with Better Therapeutic Index Than Sorafenib via Zebrafish Drug Screening Platform
Previous Article in Journal
Preclinical Characteristics of the Irreversible Pan-HER Kinase Inhibitor Neratinib Compared with Lapatinib: Implications for the Treatment of HER2-Positive and HER2-Mutated Breast Cancer
 
 
Article

Article Versions Notes

Cancers 2019, 11(6), 738; https://doi.org/10.3390/cancers11060738
Action Date Notes Link
article xml file uploaded 28 May 2019 14:42 CEST Original file -
article pdf uploaded. 28 May 2019 14:42 CEST Version of Record https://www.mdpi.com/2072-6694/11/6/738/pdf-vor
article supplementary file uploaded. 28 May 2019 14:42 CEST - https://www.mdpi.com/2072-6694/11/6/738#supplementary
article xml file uploaded 20 June 2019 08:24 CEST Update -
article xml uploaded. 20 June 2019 08:24 CEST Update https://www.mdpi.com/2072-6694/11/6/738/xml
article pdf uploaded. 20 June 2019 08:24 CEST Updated version of record https://www.mdpi.com/2072-6694/11/6/738/pdf
article supplementary file uploaded. 20 June 2019 08:24 CEST - https://www.mdpi.com/2072-6694/11/6/738#supplementary
article html file updated 20 June 2019 08:25 CEST Original file -
article html file updated 5 July 2019 18:44 CEST Update -
article html file updated 5 July 2019 18:44 CEST Update -
article html file updated 20 October 2019 21:38 CEST Update -
article html file updated 12 February 2020 15:52 CET Update -
article html file updated 19 July 2022 19:15 CEST Update https://www.mdpi.com/2072-6694/11/6/738/html
Back to TopTop